TP53 and cancer: The same three cancer types also showed persistent increases in specific genomic instability indicators (that is, chromosomal aneuploidy score20, loss of heterozygosity (LOH) genome fraction, WGD22 and TP53 alterations23) in the metastatic cohort (Fig. 1e and Supplementary Table 2).